A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants

Clinical trial NCT02093923 · COMPLETED

Trial details

NCT number: NCT02093923
Sponsor: Shire
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)

Start date: 2014-05-14
Primary completion: 2015-05-18
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.